Ethos Financial Group’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $125K | Hold |
|
|||||
|
2025
Q2 | $22.5K | Hold |
|
|||||
|
2025
Q1 | $50.4K | Hold |
|
|||||
|
2024
Q4 | $50.4K | Hold |
|
|||||
|
2024
Q3 | $46K | Hold |
|
|||||
|
2024
Q2 | $59K | Hold |
|
|||||
|
2024
Q1 | $84K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $60.8K | Sell |
|
|||||
|
2023
Q2 | $205K | Buy |
|
|||||
|
2023
Q1 | $205K | Hold |
|
|||||
|
2022
Q4 | $126K | Buy |
|